Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate 68Ga-Her2-affibody PET/CT Imaging of Her2 Expression in Tumors

NCT06289517 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06289517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06289517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate 68Ga-Her2-affibody PET/CT Imaging of Her2 Expression in Tumors
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 28, 2024
Completion date
August 30, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms